ARTICLE SUMMARY:
Is women's health finally having its moment? With a suite of minimally invasive reproductive-assist devices, Femasys may be poised to be the first big success in women's health and earlier-stage Amber Therapeutics recently raised $100 million for its UI implant. Also inside, Medtronic's surprise CGM deal with Abbott; growing the TAVR market through new applications; Peter Fitzgerald aims to expand options for Israeli and Palestinian youth, and a look at new players in plastic surgery.
